BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saleh R, Toor SM, Al-Ali D, Sasidharan Nair V, Elkord E. Blockade of PD-1, PD-L1, and TIM-3 Altered Distinct Immune- and Cancer-Related Signaling Pathways in the Transcriptome of Human Breast Cancer Explants. Genes (Basel) 2020;11:E703. [PMID: 32616706 DOI: 10.3390/genes11060703] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Mackenzie NJ, Nicholls C, Templeton AR, Perera MP, Jeffery PL, Zimmermann K, Kulasinghe A, Kenna TJ, Vela I, Williams ED, Thomas PB. Modelling the tumor immune microenvironment for precision immunotherapy. Clin & Trans Imm 2022;11. [DOI: 10.1002/cti2.1400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Nai Y, Du L, Shen M, Li T, Huang J, Han X, Luo F, Wang W, Pang D, Jin A. TRAIL-R1-Targeted CAR-T Cells Exhibit Dual Antitumor Efficacy. Front Mol Biosci 2021;8:756599. [PMID: 34988114 DOI: 10.3389/fmolb.2021.756599] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Bailly C, Thuru X, Quesnel B. Modulation of the Gal-9/TIM-3 Immune Checkpoint with α-Lactose. Does Anomery of Lactose Matter? Cancers (Basel) 2021;13:6365. [PMID: 34944985 DOI: 10.3390/cancers13246365] [Reference Citation Analysis]
4 Masoumi E, Tahaghoghi-Hajghorbani S, Jafarzadeh L, Sanaei MJ, Pourbagheri-Sigaroodi A, Bashash D. The application of immune checkpoint blockade in breast cancer and the emerging role of nanoparticle. J Control Release 2021;340:168-87. [PMID: 34743998 DOI: 10.1016/j.jconrel.2021.10.018] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
5 Cong Y, Liu J, Chen G, Qiao G. The Emerging Role of T-Cell Immunoglobulin Mucin-3 in Breast Cancer: A Promising Target For Immunotherapy. Front Oncol 2021;11:723238. [PMID: 34504800 DOI: 10.3389/fonc.2021.723238] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Nie L, Liu XY, Ma RJ, Yuan XL, Jiang L, Yang J, Hu AX, Li Z, Zhu ZM. [The expression and prognostic value of PD-1, TIM-3, LAG-3 and BTLA in extranodal NK/T cell lymphoma]. Zhonghua Xue Ye Xue Za Zhi 2021;42:598-602. [PMID: 34455749 DOI: 10.3760/cma.j.issn.0253-2727.2021.07.012] [Reference Citation Analysis]
7 Luo X, Wang H, Ji D. Carbon nanotubes (CNT)-loaded ginsenosides Rb3 suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer. Aging (Albany NY) 2021;13:17177-89. [PMID: 34111025 DOI: 10.18632/aging.203131] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
8 Zuo S, Song J, Zhang J, He Z, Sun B, Sun J. Nano-immunotherapy for each stage of cancer cellular immunity: which, why, and what? Theranostics 2021;11:7471-87. [PMID: 34158861 DOI: 10.7150/thno.59953] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
9 Cinier J, Hubert M, Besson L, Di Roio A, Rodriguez C, Lombardi V, Caux C, Ménétrier-Caux C. Recruitment and Expansion of Tregs Cells in the Tumor Environment-How to Target Them? Cancers (Basel) 2021;13:1850. [PMID: 33924428 DOI: 10.3390/cancers13081850] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]